R

RXRX PE Valuation

This table applies RXRX's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

R

RXRX Earnings Per Share

This chart tracks RXRX's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

R

RXRX Quarterly Revenue

This chart tracks RXRX's quarterly revenue over time and shows how sales are changing from year to year.

R

RXRX Free Cash Flow

This chart tracks RXRX's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

R

RXRX Net Leverage

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

R

RXRX Weekly Price

This chart uses RXRX's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

R

RXRX Weekly Moving Averages

This chart compares RXRX's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

R

RXRX Yearly ROI

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.